Skip to main content
SpringerLink
Log in

Inflammatory Bowel Disease in Pregnancy

  • Chapter
  • First Online:
Pediatric Inflammatory Bowel Disease

  • 1089 Accesses

Abstract

While the incidence of ulcerative colitis has remained stable, the incidence of Crohn disease [CD] has increased over the past few decades. It is not clear whether this is due to improved diagnostic techniques, an increase in smoking habits by young female patients [patients with CD tend to be smokers compared to people without CD], environmental or genetic influences, or other factors not yet identified. However, the consequence of this trend is a growing population of patients in their formative and childbearing years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peyrin-Biroulet L, Loftus Jr EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn disease in population-based cohorts. Inflamm Bowel Dis. 2011;17(1):471–8.

    Article  PubMed  Google Scholar 

  2. Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn disease. Am J Gastroenterol. 1989;84:31–3.

    CAS  PubMed  Google Scholar 

  3. Suris JC, Resnick MD, Cassuto N, Blum RW. Sexual behavior of adolescents with chronic disease and disability. J Adolesc Health. 1996;19(2):124–31.

    Article  CAS  PubMed  Google Scholar 

  4. Newacheck P, Halfon N. Prevalence and impact of disabling chronic conditions in childhood. Am J Public Health. 1998;88:610–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gittes EB, Strickland JL. Contraceptive choices for chronically Ill adolescents. Adolesc Med. 2005;16:635–44.

    Article  Google Scholar 

  6. Gawron LM, Gawron AJ, Kasper A, Hammond C, Keefer L. Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional study. Contraception. 2014;89:419–25.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wakeman J. Exacerbation of Crohn disease after insertion of a levonorgestrel intrauterine system: a case report. J Fam Plann Reprod Health Care. 2003;29(3):154.

    Article  PubMed  Google Scholar 

  8. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn disease. The Canadian Mesalamine for Remission of Crohn Disease Study Group. Gastroenterol. 1998;114(6):1143–50.

    Article  CAS  Google Scholar 

  9. Cornish JA, Tan E, Simillis C, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103(9):2394–400.

    Article  PubMed  Google Scholar 

  10. Cottone M, Camma C, Orlando A, et al. Oral contraceptive and recurrence in Crohn disease. Gastroenterol. 1999;116:A693.

    Article  Google Scholar 

  11. Zapata LB, Paulen ME, Cansino C, Marchbanks PA, Curtis KM. Contraceptive use among women with inflammatory bowel disease: a systematic review. Contraception. 2010;82:72–85.

    Article  PubMed  Google Scholar 

  12. Gawron LM, Goldberger A, Gawron AJ, Hammond C, Keefer L. The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:1729–33.

    Article  PubMed  Google Scholar 

  13. Coley RL, Chase-Lansdale PL. Adolescent pregnancy and parenthood: recent evidence and future direction. Am Psychol. 1998;53:152–66.

    Article  CAS  PubMed  Google Scholar 

  14. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn disease: a case control study by European collaborative group. Gut. 1986;27:821–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tiverneir N, Fumery M, Peyri-Biroulet L, Coumbel JF, Gower-Russen C. Systematic review: fertility in non-surgically treated inflammatory bowel disease. Aliment Pharmacol Thera. 2013;38:847–53.

    Article  Google Scholar 

  16. Ban L, Tata LJ, Humes DJ, Fiaschi L, Card T. Decreased fertility rates in 639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study. Aliment Pharmacol Ther. 2015;42(7):855–66.

    Article  CAS  PubMed  Google Scholar 

  17. Oza SS, Pabby V, Dodge LE, et al. In vitro fertilization in women with inflammatory bowel disease is as successful as in women from the general infertility population. Clin Gastroenterol Hepatol. 2015;13:1641–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut. 1981;22:452–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Burnell D, Mayberry J, Calcraft BJ, Morris JS, Rhodes J. Male fertility in Crohn disease. Postgrad Med J. 1986;62:269–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dejaco C, Mittemaier C, Reinisch W, et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterol. 2001;121:1048–53.

    Article  CAS  Google Scholar 

  21. Nørgård B, Pedersen L, Jacobsen J, Rasmussen SN, Sørensen HT. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception. Aliment Pharmacol Ther. 2004;19(6):679–85.

    Article  PubMed  CAS  Google Scholar 

  22. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol. 2000;95(3):684–8.

    Article  CAS  PubMed  Google Scholar 

  23. Banks B, Korelitz BI, Zetzel L. The course of non-specific ulcerative colitis: a review of twenty years of experience and late results. Gastroenterol. 1957;32:983–1012.

    CAS  Google Scholar 

  24. Miller JP. Inflammatory bowel disease in pregnancy: a review. J R Soc Med. 1986;79:221–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut. 1980;21:469–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426–30.

    Article  CAS  PubMed  Google Scholar 

  27. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn disease, pregnancy, and birth weight. Am J Gastroenterol. 2000;95:1021–6.

    Article  CAS  PubMed  Google Scholar 

  28. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007;56(6):830–7.

    Article  CAS  PubMed  Google Scholar 

  29. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: a case- controlled retrospective analysis. Br J Obstet Gynaecol. 1986;93:1124–31.

    Article  CAS  PubMed  Google Scholar 

  30. Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Complications from inflammatory bowel disease during pregnancy and delivery. Clin Gastroenterol Hepatol. 2012;10:1246–52.

    Article  PubMed  Google Scholar 

  31. Kane SV, Hanauer SB, Kiesel J, Shih L, Tyan D. HLA disparity determines disease activity through pregnancy in women with IBD. Am J Gastroenterol. 2004;99(8):1523–6.

    Article  PubMed  Google Scholar 

  32. Nwokolo C, Tan WC, Andrews HA, Allan RN. Surgical resections in parous patients with distal ileal and colonic Crohn disease. Gut. 1994;35:220–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006;101(7):1539–45.

    Article  PubMed  Google Scholar 

  34. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB. MRI in the diagnosis of Crohn disease in two pregnant women. J Clin Gastroenterol. 1993;17:244–7.

    Article  CAS  PubMed  Google Scholar 

  35. Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16:347–68.

    CAS  PubMed  Google Scholar 

  36. Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci. 1996;41:2353–61.

    Article  CAS  PubMed  Google Scholar 

  37. Qureshi WA, Rajan E, Adler DG, et al. ASGE guideline: guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc. 2005;61(3):357–62.

    Article  PubMed  Google Scholar 

  38. Friedel D, Stavropoulos S, Iqbal S, Cappell MS. Gastrointestinal endoscopy in the pregnant woman. World J Gastrointest Endo. 2014;6:156–67.

    Article  Google Scholar 

  39. Sachar D. Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight. Gut. 1998;43:316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Warrell DW, Taylor R. Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet. 1968;1:117–8.

    Article  CAS  PubMed  Google Scholar 

  41. Coelho J, Beaugerie L, Colombel JF. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut. 2011;60(2):198–203.

    Article  PubMed  Google Scholar 

  42. Einarson A, Mastroiacovo P, Arnon J, et al. Prospective, controlled multicenter study of loperamide in pregnancy. Can J Gastroenterol. 2000;14:185–7.

    Article  CAS  PubMed  Google Scholar 

  43. Bonapace E, Fisher RS. Constipation and diarrhea in pregnancy. Gastroenterol Clin NA. 1998;27:197–211.

    Article  Google Scholar 

  44. Briggs G, Freeman R, Yaffee S. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. New Jersey: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  45. Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord. 2003;3:81–92.

    PubMed  Google Scholar 

  46. Esbjorner E, Jarnerot G, Wranne L. Sulphasalazine and sulphapyridine levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediart Sand. 1987;76:137–42.

    Article  CAS  Google Scholar 

  47. Moody GA, Probert C, Jayanthi V, Mayberry JF. The effects of chronic ill health and treatment with sulphasalazine on fertility amongst men and female patients with inflammatory bowel disease in Leicestershire. Int J Color Dis. 1997;12:220–4.

    Article  CAS  Google Scholar 

  48. Hernandez-Diaz S, Werler MM, Mitchell AA, et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343:1608–14.

    Article  CAS  PubMed  Google Scholar 

  49. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol. 2008;25(2):271–5.

    Article  CAS  PubMed  Google Scholar 

  50. Colombel JF, Brabant G, Gubler MC, et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? [letter] [see comments]. Lancet. 1994;344:620–1.

    Article  CAS  PubMed  Google Scholar 

  51. Hernández-Díaz S, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect. 2009;117(2):185–9.

    Article  PubMed  CAS  Google Scholar 

  52. Diav-Citrin O, Shechtman S, Ornoy A, et al. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study. Teratology. 2001;63:186–92.

    Article  CAS  PubMed  Google Scholar 

  53. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol. 1993;82:348–52.

    CAS  PubMed  Google Scholar 

  54. Linseman DA, Hampton LA, Branstetter DG. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam Appl Toxicol. 1995;28:59–64.

    Article  CAS  PubMed  Google Scholar 

  55. Moskovitz DN, Bodian C, Chapman ML, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol. 2004;99:656–61.

    Article  PubMed  Google Scholar 

  56. Loebstein R, Addis A, HO E, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother. 1998;42:1336–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Beitins IZ, Bayard F, Migeon CJ, et al. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr. 1972;81:936–45.

    Article  CAS  PubMed  Google Scholar 

  58. Mogadam M, Korelitz BI, Ahmed SW, Dobbins WD, Baiocco PJ. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol. 1981;75:265–9.

    CAS  PubMed  Google Scholar 

  59. Armenti V, Ahlswede KM, Ahlswede RA, et al. National transplant pregnancy registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation. 1994;57(4):502–6.

    Article  CAS  PubMed  Google Scholar 

  60. Ramsey-Goldman RSE. Immunosuppressive drug use during pregnancy. Rheum Clin NA. 1997;23:149–67.

    Article  CAS  Google Scholar 

  61. Saarikoski S, Seppala M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol. 1973;115:1100–6.

    Article  CAS  PubMed  Google Scholar 

  62. Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004;2:731–43.

    Article  CAS  PubMed  Google Scholar 

  63. Matalon ST, Ornoy A, Lishner M. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs. (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Reprod Toxicol. 2004;18:219–30.

    Article  CAS  PubMed  Google Scholar 

  64. Francella A, Dyan A, Present DH, et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003;124:9–17.

    Article  CAS  PubMed  Google Scholar 

  65. Norgard B, Pedersen L, Sorensen HT, et al. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther. 2003;17:827–34.

    Article  CAS  PubMed  Google Scholar 

  66. Goldenberg M, Bider D, Oelsner G, et al. Methotrexate therapy of tubal pregnancy. Hum Reprod. 1993;8:660–6.

    Article  CAS  PubMed  Google Scholar 

  67. Gromnica-Ihle E, Kruger K. Use of methotrexate in young patients with regard to the reproductive system. Clin Exp Rheum. 2010;28:S80–4.

    CAS  Google Scholar 

  68. Katz JA, Antoni C, Lichenstein GR, et al. Outcome of pregnancy in female patients receiving infliximab for the treatment of Crohn disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99:2385–92.

    Article  PubMed  Google Scholar 

  69. Kane SV, Acquah LA, Mahadevan U, Cucchiara S, Hyams JS, et al. The London position statement of the world congress of gastroenterology on biological therapy for IBD with the European Crohn and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011;106(2):214–23.

    Article  CAS  Google Scholar 

  70. Seirafi M, de Vroey B, Amiot A, et al. Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease. Aliment Pharmacol Thera. 2014;40:363–73.

    Article  CAS  Google Scholar 

  71. Mahadevan U, Wolf DC, Dubinsky MC, et al. Placental transfer of anti tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013;11:286–92.

    Article  CAS  PubMed  Google Scholar 

  72. Pasut G. Pegylation of biological molecules and potential benefits: pharmacologic properties of certolizumab pegol. BioDrugs. 2014;28:S15–30.

    Article  PubMed  Google Scholar 

  73. Zelenkova Z, van der Ent C, Bruin KF, et al. Effects of discontinuing anti tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. Clin Gastroenterol Hepatol. 2013;11:318–21.

    Article  CAS  Google Scholar 

  74. Hellwig K, Haghikia A, Gold R. Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment. Mult Scler. 2011;17(8):958–63.

    Article  PubMed  Google Scholar 

  75. Vedolizumab Prescribing Information. 2014 Takeda. Accessed at www.entyvio.com on Dec 30, 2016.

  76. Motta M, Ciardelli L, Marconi M, et al. Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents. Am J Perinatol. 2007;24(8):441–7.

    Article  PubMed  Google Scholar 

  77. Khan HA. Cyclosporin-A augments respiratory burst of whole blood phagocytes in pregnant rats. Immunopharmacol Immunotoxicol. 2007;29(3–4):367–74.

    Article  CAS  PubMed  Google Scholar 

  78. Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy. Rheum Dis Clin N Am. 1997;23:149–67.

    Article  CAS  Google Scholar 

  79. Bertschinger P, Himmelmann A, Follath F, et al. Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol. 1995;90:330.

    CAS  PubMed  Google Scholar 

  80. Kornbluth A, Reddy D. Management and outcome of severe colitis in pregnancy. Am J Gastroenterol. 2002;97:P705.

    Article  Google Scholar 

  81. Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanauer SB. Thalidomide therapy for patients with refractory Crohn disease: an open-label trial. Gastroenterol. 1999;117:1271–7.

    Article  CAS  Google Scholar 

  82. Vasiliauskas EA, Kam LY, Abreu-Martin MT, et al. An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn disease. Gastroenterology. 1999;117:1278–87.

    Article  CAS  PubMed  Google Scholar 

  83. Sandborn WJ. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of compicated proximal small bowel and fistulizing Crohn disease. Am J Gastroenterol. 1997;92:876–9.

    CAS  PubMed  Google Scholar 

  84. Neurath MF, Wanitschke R, Peters M. Randomized trial of mycophenolate versus azathioprine for treatment of chronic active Crohn disease. Gut. 1999;44:625–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Kainz A, Harabacz I, Cowlrick IS, Gadgil S, Hagiwara D. Analysis of 100 pregnancy outcomes in female patients treated systemically with tacrolimus. Transpl Int. 2000;13:S299–300.

    Article  PubMed  Google Scholar 

  86. Jacobson L, Clapp DH. Total parenteral nutrition in pregnancy complicated by Crohn disease. JPEN. 1987;11:93–6.

    Article  CAS  Google Scholar 

  87. Nugent F, Rajala M, O’Shea RA, et al. Total parenteral nutrition in pregnancy: conception to delivery. JPEN. 1987;11:424–7.

    Article  CAS  Google Scholar 

  88. Park YK, Meier ER, Song WO. Characteristics of teenage mothers and predictors of breastfeeding initiation in the Michigan WIC Program in 1995. Women, infants, and children. J Hum Lact. 2003;19:50–6.

    Article  PubMed  Google Scholar 

  89. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2005;100(1):102–5.

    Article  PubMed  Google Scholar 

  90. Moffatt DC, Ilnyckyj A, Bernstein CN. A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the postpartum period. Am J Gastroenterol. 2009;104(10):2517–23.

    Article  PubMed  Google Scholar 

  91. Klotz U, Harings-Kaim A. Negligible excretion of 5-aminosalicylic acid in breast milk. Lancet. 1993;342:618–9.

    Article  CAS  PubMed  Google Scholar 

  92. Nelis GF. Diarrhoea due to 5-aminosalicyclic acid in breast milk. Lancet. 1989;1:383.

    Article  CAS  PubMed  Google Scholar 

  93. Christensen LA. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man. Dan Med Bull. 2000;47(1):20–41.

    CAS  PubMed  Google Scholar 

  94. Christensen LA, Dahlerup JF, Nielsen MJ, Fallingborg JF, Schmiegelow K. Azathioprine treatment during lactation. Aliment Pharmacol Ther. 2008;28(10):1209–13.

    Article  CAS  PubMed  Google Scholar 

  95. Nyberg G, Haljamae U, Kjemeller I, et al. Breast-feeding during treatment with cyclosporine. Transplantation. 1998;65:253–5.

    Article  CAS  PubMed  Google Scholar 

  96. Munoz-Flores-Thiagarajan KD, Easterling T, Bond EF, et al. Breast-feeding by a cyclosporine-treated mother. Obstet Gynecol. 2001;97:816–8.

    CAS  PubMed  Google Scholar 

  97. Ost L, Wettrell G, Rane A, et al. Prednisolone excretion in human milk. J Pediatr. 1985;106:1008–11.

    Article  CAS  PubMed  Google Scholar 

  98. Kane S. Breastfeeding and IBD: safety and management issues. Inflamm Bowel Dis Monit. 2004;6:50–2.

    Google Scholar 

  99. Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn disease before and after delivery. J Clin Gastroenterol. 2009;43(7):613–6.

    Article  CAS  PubMed  Google Scholar 

  100. Ben Horin S, Yavzori M, Katz L, et al. Adalimumab level in breast milk of a nursing mother. Clin Gastroenterol Hepatol. 2010;8:475–6.

    Article  PubMed  Google Scholar 

  101. Gibert WM, Jandial D, Field NT, et al. Birth outcomes in teenage pregnancies. J Matern Fetal Neonatal Med. 2004;16:265–70.

    Article  Google Scholar 

  102. Ilnyckyj A, Blanchard JF, Rawsthorne P, Bernstein CN. Perianal Crohn disease and pregnancy: role of the mode of delivery. Am J Gastroenterol. 1999;94:3274–8.

    Article  Google Scholar 

  103. Cheng A, Oxford EC, Sauk J, et al. Impact of mode of delivery on outcomes in patients with perianal Crohn disease. Inflamm Bowel Dis. 2014;20:1391–8.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Ananthakrishnan A, Cheng A, Cagan A, et al. Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases. Dig Dis Sci. 2015;60:471–7.

    Article  CAS  PubMed  Google Scholar 

  105. Levine W, Diamond B. Surgical procedures during pregnancy. Am J Obstet Gynecol. 1961;81:1046–52.

    Article  CAS  PubMed  Google Scholar 

  106. Kelly M, Hunt TM, Wicks ACB, et al. Fulminant ulcerative colitis and parturition: a need to alter current management? Br J Obstet Gnecol. 1994;101:166–7.

    Article  Google Scholar 

  107. Anderson JB, Turner GM, Williamson RC. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med. 1987;80:492–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Hill J, Clark A, Scott NA. Surgical treatment of acute manifestations of Crohn disease during pregnancy. J R Soc Med. 1997;90:64–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Metcalf A, Dozois RR, Baert RW, et al. Pregnancy following ileal pouch-anal anastomosis. Dis Colon Rectum. 1985;28:859–61.

    Article  CAS  PubMed  Google Scholar 

  110. Olsen KOJS, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterol. 2002;122:15–9.

    Article  Google Scholar 

  111. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55(11):1575–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Pabby V, Oza SS, Dodge LE, et al. In vitro fertilization is successful in women with ulcerative colitis and ileal pouch anal anastomosis. Am J Gastroenterol. 2015;110:792–7.

    Article  PubMed  Google Scholar 

  113. Juhasz ES, Fozard B, Dozois RR, Ilstrup DM, Nelson H. Ileal pouch-anal anastomosis function following childbirth. An extended evaluation. Dis Colon Rectum. 1995;38:159–65.

    Article  CAS  PubMed  Google Scholar 

  114. Baldassano R, Ferry G, Griffiths A. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology. Hepatol Nutr. 2002;34:245–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Sunanda Kane MD, MSPH

Authors
  1. Sunanda Kane MD, MSPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunanda Kane MD, MSPH .

Editor information

Editors and Affiliations

  1. Division of GI, Hepatology & Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

    Petar Mamula

  2. Division of GI, Hepatology & Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

    Andrew B. Grossman

  3. Division of GI, Hepatology & Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

    Robert N. Baldassano

  4. Division of GI, Hepatology & Nutrition, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

    Judith R. Kelsen

  5. Division of Pediatric Gastroenterology & Nutrition, University of South Carolina School of Medicine - Greenville, Greenville, South Carolina, USA

    Jonathan E. Markowitz

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Kane, S. (2017). Inflammatory Bowel Disease in Pregnancy. In: Mamula, P., Grossman, A., Baldassano, R., Kelsen, J., Markowitz, J. (eds) Pediatric Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-49215-5_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49215-5_53

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49213-1

  • Online ISBN: 978-3-319-49215-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation